Current Affairs

Adding Radioligand to Enzalutamide Boosts OS in Metastatic CRPC

Photo of News Fetcher News FetcherFebruary 14, 2025
0 66 Less than a minute
Adding Radioligand to Enzalutamide Boosts OS in Metastatic CRPC

(MedPage Today)-San Francisco-adding radioactive offices with 177LU-Psma-617 (Pluvicto) to Enzalutamide (XTANDI). It is overall survival (OS) in patients with prostate cancer resistant to metastatic (CRPC). ..

Photo of News Fetcher News FetcherFebruary 14, 2025
0 66 Less than a minute
Photo of News Fetcher

News Fetcher

Related Articles

US partners with Colombia to take on immigration using biometric capabilities

US partners with Colombia to take on immigration using biometric capabilities

March 27, 2025
U.S. businesses sue to block Trump tariffs, say trade deficits are not an emergency

U.S. businesses sue to block Trump tariffs, say trade deficits are not an emergency

April 14, 2025
Drake’s Dad Reacts to Kendrick Lamar’s Grammys Success With ‘Not Like Us’

Drake’s Dad Reacts to Kendrick Lamar’s Grammys Success With ‘Not Like Us’

February 3, 2025
‘Move fast and break things’? Judges are telling Trump to put them back together.

‘Move fast and break things’? Judges are telling Trump to put them back together.

March 19, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button